You are here:
horvawes(1) - 副本
horvawes(1)
horvawes(1) - 副本
horvawes(1)

99% Tirzepatide

Tirzepatide is a novel dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.

Product information

Specification

CAS No.: 2023788-19-2

Molecular Formula: C₂₂₅H₃₄₈N₅₀O₆₈S

Molecular Weight: 4813.45±1

Salt Type:Na+

Appearance: White to off-white powder

Purity (HPLC):≥ 99.0%

Bacterial endotoxin:<10EU/mg

Solubility:Soluble in water≥50mg/ml

StorageStore at a temperature of 2~8℃,protected from light

Research Field

Core indications: Type 2 diabetes mellitus, obesity.

Exploratory research fields: Cardiovascular benefits, metabolic dysfunction-associated steatotic liver disease (MASLD), heart failure, Alzheimer’s disease, and other fields.

 

Our Advantages

Continuous Batch Production & Stable Quality: Capable of mass production (kg-scale manufacturing and supply), ensuring stable and continuous batch production; consistent product quality with no batch-to-batch variations.

High Purity: The product features high purity (HPLC purity ≥ 99.0%).

Lyophilized Powder: Easy to store and transport.

Customization Support: Packaging specifications can be customized according to customer requirements.

 

Precautions:

This product is intended for scientific research use only.

You may still like it